期刊文献+

不同炎性指标检测在川崎病患儿诊断中的价值 被引量:15

The value of different inflammatory indicators in children with Kawasaki disease
原文传递
导出
摘要 目的分析川崎病患儿血常规白细胞计数(WBC)、C-反应蛋白(CRP)、降钙素原(PCT)、血沉(ESR)结果,探讨其对川崎病的诊断及预测合并冠状动脉损害的价值。方法选择2018年7-12月中国科学技术大学附属第一医院儿科收治的56例川崎病患儿作为川崎病组,依据超声心动图结果,将川崎病患儿分为冠状动脉损害组(CAL组,25例)与无冠状动脉损害组(NCAL组,31例);选取40例同期间发热5~7 d的肺炎住院患儿作为感染组;另选择同期进行健康体检的32例正常儿童作为对照组。分别采用全自动白细胞计数法、免疫荧光干式定量法、魏氏法,检测各组WBC、CRP、PCT、ESR水平,分析上述指标与CAL的关系。结果川崎病组患儿的WBC、CRP、PCT及ESR水平均明显高于感染组和对照组[WBC(×10~9/L):19.22±6.43 vs. 10.89±4.56、8.48±2.15,CRP(mg/L):100.29±75.86 vs. 17.03±18.79、3.94±1.91,PCT(g/L):3.22±6.83 vs. 0.69±1.06、0.14±0.25,ESR(mm/h):73.36±28.57 vs. 27.45±13.37、8.59±4.32,均P<0.05];CAL组患儿WBC、CRP、PCT、ESR水平均明显高于NCAL组[WBC(×10~9/L):23.26±6.19 vs. 15.96±4.53,CRP(mg/L):161.11±73.15 vs. 51.24±26.45,PCT(g/L):5.59±9.54 vs. 1.30±2.06,ESR(mm/h):95.20±23.23 vs. 55.74±18.62,均P<0.05]。结论血WBC、CRP、PCT及ESR早期升高与川崎病密切相关,检测该炎症指标水平对预测CAL有重要价值,对临床早期治疗及预后评估具有重要指导作用。 Objective To analysis the results of white blood cell count(WBC), C-reactive protein(CRP), procalcitonin(PCT) and erythrocyte sedimentation rate(ESR) in children with Kawasaki disease(KD), and to explore its value in diagnosis of KD and prediction of KD with coronary artery injury(CAL) damage. Methods From July to December 2018, 56 children with KD in our Hospital were selected as KD group, including 31 children with coronary artery lesion(CAL) and 25 children with non coronary artery lesion(NCAL). Children with pneumonia who had a fever for 5-7 days in the same period were selected as the infection group(40 cases), and 32 healthy children received health screening were selected as the health group. The levels of WBC, CRP, PCT and ESR were measured by automatic white blood cell count、immunofluorescence dry quantitative method and Westergren, respectively. The relationships between those indicators and CAL were analyzed. Results The levels of WBC, CRP, PCT and ESR in children of KD group were significantly higher than those in infection group and health group [WBC(×10~9/L): 19.22±6.43 vs. 10.89±4.56, 8.48±2.15;CRP(mg/L): 100.29±75.86 vs. 17.03±18.79, 3.94±1.91;PCT(g/L): 3.22±6.83 vs. 0.69±1.06, 0.14±0.25;ESR(mm/h): 73.36±28.57 vs. 27.45±13.37, 8.59±4.32, all P<0.05]. The levels of WBC, CRP, PCT and ESR in CAL group were significantly higher than those in NCAL group [WBC(×10~9/L): 23.26±6.19 vs. 15.96±4.53;CRP(mg/L): 161.11±73.15 vs. 51.24±26.45;PCT(g/L): 5.59±9.54 vs. 1.30±2.06;ESR(mm/h): 95.20±23.23 vs. 55.74±18.62, all P<0.05]. Conclusion The early elevation of WBC, CRP, PCT and ESR are closely related to KD. The detections of those inflammatory indicators are of important value for predicting CAL, and have great guiding role in early clinical treatment and prognosis evaluation.
作者 陈玉萍 张兰 CHEN Yu-ping;ZHANG Lan(Department of Pediatrics,the First Affiliated Hospital of University of Science and Technology of China,Hefei,Anhui 230001,China)
出处 《中华全科医学》 2020年第3期362-364,共3页 Chinese Journal of General Practice
基金 安徽省高等学校自然科学研究一般项目(KJ2015B065by)。
关键词 川崎病 冠状动脉病变 白细胞计数 C-反应蛋白 降钙素原 血沉 Kawasaki disease Coronary artery lesion White blood cell count C-reactive protein Procalcitonin Erythrocyte sedimentation rate
  • 相关文献

参考文献8

二级参考文献70

  • 1张伟,李秋,赵晓东,唐雪梅,王晓刚,王墨,吴道奇,欧茜,杨锡强.川崎病发生冠状动脉病变危险因素的Logistic回归分析[J].中国实用儿科杂志,2006,21(1):51-53. 被引量:40
  • 2张永兰,杜忠东.小儿川崎病冠状动脉损伤的危险因素[J].中国实用儿科杂志,2006,21(10):742-744. 被引量:48
  • 3奚立,桂永浩,盛锋,徐素梅.Harada评分预测川崎病冠状动脉病变的临床意义[J].临床儿科杂志,2007,25(4):309-311. 被引量:14
  • 4杜忠东,贾立群,张永兰,王玉,林瑶,刘冲.血管超声检测川崎病合并体循环动脉瘤的研究[J].中华儿科杂志,2007,45(5):395-396. 被引量:5
  • 5胡亚美,江载芳,诸福棠.实用儿科学.第7版.北京:人民卫生出版社,2003:1174-1184.
  • 6Arj-Ong S, Thakkinstian A, McEvoy M, et al. A systematic review and meta-analysis of tumor necrosis factor 0t-308 polymorphism and Kawasaki disease I J]. Pediatr Int, 2010, 52 (4) : 527-532.
  • 7牟静飞,覃敏,冯军坛,等.川崎病患儿并发冠状动脉病变的高危因素分析[J].医学信息,2013,z6(7):237.
  • 8Shimizu C, Matsubara T, Onouchi Y, et al. Matrix metalloproteinase haplotypes associated with coronary arteryaneurysm formation in patients with Kawasaki disease [ J ]. J Hum Genet, 2010, 55(12): 779-784.
  • 9Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [J]. Pediatrics, 2004, 114(6): 1705-1733.
  • 10Yoshihiro, Onouehi. Molecular genetics of Kawasaki disease [J]. Pediatric Research, 2009, 65(5Pt2) : 46R-54R.

共引文献217

同被引文献183

引证文献15

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部